Cargando…

Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose

Detalles Bibliográficos
Autores principales: Attolico, Immacolata, Tarantini, Francesco, Carluccio, Paola, Musto, Pellegrino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Fondazione Ferrata Storti 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052926/
https://www.ncbi.nlm.nih.gov/pubmed/35045696
http://dx.doi.org/10.3324/haematol.2022.280619
_version_ 1784696887371104256
author Attolico, Immacolata
Tarantini, Francesco
Carluccio, Paola
Musto, Pellegrino
author_facet Attolico, Immacolata
Tarantini, Francesco
Carluccio, Paola
Musto, Pellegrino
author_sort Attolico, Immacolata
collection PubMed
description
format Online
Article
Text
id pubmed-9052926
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-90529262022-05-13 Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose Attolico, Immacolata Tarantini, Francesco Carluccio, Paola Musto, Pellegrino Haematologica Comments Fondazione Ferrata Storti 2022-01-20 /pmc/articles/PMC9052926/ /pubmed/35045696 http://dx.doi.org/10.3324/haematol.2022.280619 Text en Copyright© 2022 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Comments
Attolico, Immacolata
Tarantini, Francesco
Carluccio, Paola
Musto, Pellegrino
Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose
title Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose
title_full Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose
title_fullStr Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose
title_full_unstemmed Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose
title_short Serological response following anti-SARS-CoV-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose
title_sort serological response following anti-sars-cov-2 vaccination in hematopoietic stem cell transplantation patients depends upon time from transplant, type of transplant and “booster”dose
topic Comments
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052926/
https://www.ncbi.nlm.nih.gov/pubmed/35045696
http://dx.doi.org/10.3324/haematol.2022.280619
work_keys_str_mv AT attolicoimmacolata serologicalresponsefollowingantisarscov2vaccinationinhematopoieticstemcelltransplantationpatientsdependsupontimefromtransplanttypeoftransplantandboosterdose
AT tarantinifrancesco serologicalresponsefollowingantisarscov2vaccinationinhematopoieticstemcelltransplantationpatientsdependsupontimefromtransplanttypeoftransplantandboosterdose
AT carlucciopaola serologicalresponsefollowingantisarscov2vaccinationinhematopoieticstemcelltransplantationpatientsdependsupontimefromtransplanttypeoftransplantandboosterdose
AT mustopellegrino serologicalresponsefollowingantisarscov2vaccinationinhematopoieticstemcelltransplantationpatientsdependsupontimefromtransplanttypeoftransplantandboosterdose